Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,253 articles

Articles by Daniel Marsh

707 Cayman Holdings Surges Over 200% After Adding Digital Assets Expert to Board
Markets

707 Cayman Holdings Surges Over 200% After Adding Digital Assets Expert to Board

Shares of 707 Cayman Holdings (NASDAQ:JEM) more than tripled Tuesday after the company announced the appointment of Robin Hoksnes Karlsen to its board, with volume surging to 82.4 million shares.

JEM
Ondas Rises Despite Resale Overhang, Defense Orders Fuel Rally
Markets

Ondas Rises Despite Resale Overhang, Defense Orders Fuel Rally

Ondas Inc. (ONDS) shares rose 3.4% on Tuesday, supported by strong defense order momentum that outweighs a new 3.38 million share resale filing.

ONDS AVAV KTOS RCAT LMT
Dow Edges Up But Breadth Widens, Caterpillar and Apple Lead
Markets

Dow Edges Up But Breadth Widens, Caterpillar and Apple Lead

The Dow Jones Industrial Average edged higher Tuesday, driven by gains in Caterpillar and Apple, but breadth remained weak as decliners outnumbered advancers on the NYSE.

CAT AAPL GOOGL VZ
Nasdaq Leads Quarter-End Rally Amid Narrow Market Breadth
Markets

Nasdaq Leads Quarter-End Rally Amid Narrow Market Breadth

U.S. stocks rose Tuesday with the Nasdaq outpacing, but breadth remained negative as decliners topped advancers. Mixed labor data and AI spending focus set the tone.

SPY QQQ DIA IWM NVDA AAPL MSFT TSLA FDX NKE GOOGL AMZN JPM
EchoStar Falls as Dish DBS Bankruptcy Looms, Convertible Note Deadline Nears
Markets

EchoStar Falls as Dish DBS Bankruptcy Looms, Convertible Note Deadline Nears

EchoStar shares fell 1.5% as Dish DBS bankruptcy reports emerge, with the June 30 conversion deadline for $1.9 billion in convertible notes adding pressure.

QQQ SPY SATS T
Redwire Soars on Taiwan Drone Deal Amid $500M Stock Sale Concerns
Markets

Redwire Soars on Taiwan Drone Deal Amid $500M Stock Sale Concerns

Redwire (RDW) shares jumped 4.4% on a Taiwan Coast Guard drone deal, but the stock faces headwinds from a $500 million at-the-market offering and removal from the Russell Microcap Index.

RDW IWM SPY
Centessa's Final Trade Values Eli Lilly CVR at 28 Cents on the Dollar
Markets

Centessa's Final Trade Values Eli Lilly CVR at 28 Cents on the Dollar

Centessa's final trade at $40.50 values Eli Lilly's $9 contingent value right at $2.50, or 27.8 cents per dollar, as the acquisition closes and ADS trading halts.

LLY XBI IBB ALKS
Clearwater Analytics Ends Trading at $24.56, Closing $8.4B Buyout
Markets

Clearwater Analytics Ends Trading at $24.56, Closing $8.4B Buyout

Clearwater Analytics shares traded their last session at $24.56, just above the $24.55 deal price, completing an $8.4B all-cash buyout by Permira and Warburg Pincus.

CWAN
Honeywell Aerospace Holds Steady After S&P 500 Debut, Cash Flow Goals in Focus
Markets

Honeywell Aerospace Holds Steady After S&P 500 Debut, Cash Flow Goals in Focus

Honeywell Aerospace shares edged up after joining the S&P 500, as the market weighs its ambitious free cash flow goals and supply chain outlook.

HON CAG GE RTX LMT
Verizon Shares Slide on Starlink Threat, BT Deal Fails to Impress
Markets

Verizon Shares Slide on Starlink Threat, BT Deal Fails to Impress

Verizon shares fell 5.3% in premarket trading as Starlink's mobile ambitions outweighed its BT Group joint venture, pushing the dividend yield to 6.4%.

VZ SPY XLC T TMUS CHTR CMCSA
Unicycive Therapeutics Plunges After FDA Issues Second CRL on Kidney Drug
Markets

Unicycive Therapeutics Plunges After FDA Issues Second CRL on Kidney Drug

Unicycive Therapeutics shares plunged nearly 48% in premarket trading Tuesday after the FDA issued a second complete response letter for its kidney disease drug, oxylanthanum carbonate, due to third-party manufacturing issues.

UNCY AKBA SAN
Jack in the Box Surges on Russell Microcap Inclusion and Short Squeeze
Markets

Jack in the Box Surges on Russell Microcap Inclusion and Short Squeeze

Jack in the Box (JACK) shares surged 31% since Friday, driven by Russell Microcap inclusion and a short squeeze, with volume spiking to 4x the average.

JACK